Woodline Partners LP

Position in SVRA — Savara Inc

CIK 1784547 San Francisco, CA

Position in SVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$23,178,349

-$2,416,830 QoQ

Shares Held

4,245,119

+0.0% QoQ

Ownership

2.07%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#14

of 184 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,320,901,631 across 188 Biotechnology names. SVRA ranks #46 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
5	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
6	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
7	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750
8	CYTK	Cytokinetics Inc	1,000,428	$65,938,209

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,178,349	4,245,119	+0.0%	Shares	Sole	2026-05-15
2025-12-31	$25,595,179	4,244,640	+1689.3%	Shares	Sole	2026-02-17
2025-09-30	$846,878	237,221	+52.2%	Shares	Sole	2025-11-14
2025-06-30	$355,360	155,860	-38.1%	Shares	Sole	2025-08-14
2025-03-31	$697,796	251,912	-90.6%	Shares	Sole	2025-05-15
2024-12-31	$8,248,899	2,686,938	+16.6%	Shares	Sole	2025-02-14
2024-09-30	$9,774,026	2,305,195	+514.9%	Shares	Sole	2024-11-14
2020-12-31	$431,139	374,904	-36.8%	Shares	Sole	2021-02-16
2020-09-30	$647,017	593,594	+61.1%	Shares	Sole	2020-11-16
2020-06-30	$917,365	368,420	+5.6%	Shares	Sole	2020-08-14
2020-03-31	$739,765	348,946	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.